Skip to main navigation Skip to search Skip to main content

Phase IB Dose-Escalation and Expansion Study of AKT kinase inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-Resistant Ovarian Cancer

  • Sarah P Blagden
  • , Anne L Hamilton
  • , Linda Mileshkin
  • , Shirley Wong
  • , Agnieszka Michael
  • , Marcia Hall
  • , Jeffrey C Goh
  • , Alla S Lisyanskaya
  • , Michelle DeSilvio
  • , Eleni Frangou
  • , Euan A Stronach
  • , Prashanth Gopalakrishna
  • , Tarek M Meniawy
  • , Hani Gabra

Research output: Contribution to journalArticlepeer-review

72 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Phase IB Dose-Escalation and Expansion Study of AKT kinase inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-Resistant Ovarian Cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science